A major US pharmacy chain is overhauling its packaging for generic over-the-counter medications, swapping decades-old plastic bottles for aluminum. The change carries implications for packaging procurement, recyclability, and supply chain sustainability — and for now, it applies only to a narrow product set.
Why CVS Is Making the Switch
CVS is replacing hard plastic containers with aluminum for its store-brand versions of value-size allergy and pain relief medications. The change comes from a broader brand refresh, according to the company — a move that follows a downsizing effort that closed 270 stores across the US about a year ago. In public statements, CVS says it is redesigning its branding to make finding medications easier, and that the aluminum packaging also helps counter perceptions tied to widespread in-store locking of products.
Mike Wier, vice president of store brands at CVS, wrote in an email to WIRED: “For OTC medications, aluminum packaging offers several practical and sustainability benefits. Like more traditional packaging options, aluminum provides a strong barrier to help maintain stability and shelf life.”
The new bottles are lighter than the plastic versions, though CVS has not disclosed the exact weight difference. The pills inside remain unchanged, though they may make more noise in the aluminum container.
Quantified Impact: Weight, Price, and Recyclability
The transition to aluminum affects three key supply chain dimensions: logistics cost, consumer price, and end-of-life processing.
| Attribute | Plastic Bottles | Aluminum Bottles | Source Note |
|---|---|---|---|
| Material | Hard plastic | Aluminum | — |
| Weight | Heavier | Lighter | Exact difference not disclosed by CVS |
| Retail price | — | No increase after switch | CVS confirms no price change |
| Recyclability | Accepted in fewer recycling programs | More broadly recyclable | Aluminum is accepted in more facilities |
| Cap recyclability | Requires removal | Same cap, must be removed | Caps are identical and not recyclable with bottle base |
Proper recycling still requires label removal and cap removal, per Mike Wier. The caps themselves are unchanged from the plastic bottles and cannot go in the same bin as the bottle base.
Industry Response and Best-Practice Alternatives
CVS has not announced any specific supplier changes or cost data tied to the aluminum sourcing. The company is rolling out the new bottles first for its store-brand value-size versions of medications with the same active ingredients as Allegra, Benadryl, Claritin, Zyrtec, Tylenol, and Advil. These are the larger containers of generic allergy and pain relief products.
For procurement teams, the switch signals a potential shift in packaging specifications. Aluminum is generally sourced from different supply chains than plastic, and may involve different lead times and commodity price exposure. However, CVS has not commented on whether its packaging suppliers have changed or whether existing contracts were amended.
Forward Outlook: What to Watch
CVS is taking a cautious approach. “For now, the aluminum bottles are available only for select over-the-counter meds,” the article states. The company says it is waiting to see how customers respond before expanding the aluminum bottles to more medications or using them for prescription orders.
That means the current rollout is essentially a pilot. If successful, it could pave the way for broader adoption across the pharmacy chain — potentially affecting prescription drug packaging, which represents a much larger volume of pill bottles. Supply chain planners should monitor customer acceptance rates and any subsequent announcements from CVS regarding expanded use.
For procurement and sustainability leaders, the case study highlights the importance of material selection in packaging design. Aluminum offers higher recyclability and a strong barrier, but it also introduces new sourcing considerations and potential noise complaints from pill movement. CVS’s decision to hold prices steady suggests the material cost differential is either negligible or absorbed by the company in this initial phase.
Sources:
